Enveric Biosciences, Inc. — Director's Dealing 2021

Mar 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2021-03-04

Reporting Person: Van Buiten John (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-04	Common Stock	A	25000	—	Acquired	25000	Direct

Footnotes

F1: Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the "Plan"). Such shares shall vest in full on December 31, 2021, if the stock price of the issuer equals or exceeds $4.64, subject to the terms and conditions of the Plan and the reporting person's restricted stock award agreement.

F2: Includes 25,000 unvested shares of restricted stock.